News

Hope comes in a clinical trial: Brad’s remarkable story

When Brad’s medullary thyroid cancer returned after a surgical procedure, he enrolled in a clinical trial. Now, his cancer is nearly undetectable.

Colonoscopies finding a high rate of early onset colorectal cancer, Providence study finds

Providence Swedish Neuroscience Institute (PSNI) Reaches Milestone in Reducing Global Burden of Glioblastoma

PSNI collaborates with Seattle-based HDT Bio on preparations for trialing novel treatment to breach blood-brain barrier

Providence's environmental stewardship efforts net Practice Greenhealth’s highest honor

Providence today received a Greenhealth Top Health System Award by Practice Greenhealth. The award is Practice Greenhealth’s highest honor for health systems.

Providence researchers head to Chicago for leading cancer conference

Researchers at Earle A. Chiles Research Institute, a division of Providence Cancer Institute of Oregon, are helping shape the future of cancer care at the 2026 ASCO Annual Meeting in Chicago.

Providence study finds AI ambient listening tool modestly reduces documentation burden, improves provider efficiency

Published in JAMA Network Open, a new Providence study uses real-world data to show how AI ambient listening reduces documentation burden, improving efficiency and clinician focus on patient care.

Providence study finds low radiation exposure during TAVR procedures, offers reassurance for physicians considering cardiology

Radiation exposure during TAVR procedures was low overall across nearly 9,000 cases performed at Providence from 2018 to 2022, according to a new Providence study.

Providence provides $2.1 billion in community benefit in 2025 to address and respond to the community’s greatest needs

Adoptive cell therapy: Phase III study open for people with advanced melanoma

Inside the IMA203 phase III trial enrolling patients at Providence Cancer Institute.

Providence to participate in federally funded research for early detection of a behavioral health crisis

Providence is joining a nationwide, federally funded research project to develop a Large Health Behavior Model.

Providence’s Dr. Brian Chesebro named ‘Visionary Changemaker’ for environmental stewardship

Brian Chesebro, M.D. received the 2026 Visionary Changemaker award for his leadership driving innovation in healthcare sustainability and emissions reduction.

It started with one bandage, and a patient’s smile

How novelty bandages have become a beloved tradition at Providence Cancer Institute Newberg Clinic.

New guidelines for treating head and neck cancer could be a game changer

New ASCO guidelines are designed to make the full body of evidence accessible to clinicians across specialties, including those who may not work routinely with a head and neck surgeon.

Communities invest nearly $500 million in 2025 to Providence philanthropy, new report shows

More than 40,000 donors to Providence foundations fund critical research, clinical breakthroughs, patient support services and technological advances in communities across the Western U.S.

New Providence study identifies provider-patient relationships as central to colorectal cancer screening disparities

A new Providence study identifies barriers to colorectal cancer screening among racially diverse communities and is helping to shape outreach efforts to improve screening rates.

Providence receives esteemed NIH grant for ‘paradigm shift’ in head and neck cancer treatments

Providence cancer researchers will use a $3.4-million federal grant to study why a new treatment regimen is showing better outcomes against tumors that have been difficult to treat in the past.

VOICES of Black Women: A community study in cancer prevention and care

A new study focused on stories will change health outcomes for Black women.

Leading the way: Providence researchers at AACR Annual Meeting

The annual AACR meeting draws the most innovative cancer researchers seeking breakthroughs in treatments.

A quiet lifeline: Meet the volunteer at Jill Lematta Learning Center

Cancer resources and compassion are plentiful in a quiet space at Providence Cancer Institute Franz Clinic.